Digital Therapeutics (DTx) represent one of the most important topics in the Italian and international pharmaceutical sector. Our research focuses on how pharmaceutical and technological companies, both startups and established firms, may collaborate with...
- Startup – Corporate collaboration to develop DTx
- The New Era of Programmable Medicines
- What are DTx Digital Excipients?
- Programmable Medicines and Digital Biotechnology
- Digital Therapeutics – What They Are, What They Will Be
- Digital Therapeutic to Treat Adjustment Disorders during COVID-19
- FDA has approved Somryst, a Digital Therapeutic to treat chronic insomnia
- Research & Development of Digital Therapeutics